Manoj Reddy, Founder and President at Integrative Oncology Working Group, shared on LinkedIn:
“When an effective cancer treatment begins to affect the kidneys, what comes next?
Join us for our next Integrative Oncology Working Group Grand Rounds:
Օnco-Nephrology crossroads: Renal Complications from Targeted Cancer Therapies
Prakash Gudsoorkar, MD, Associate Professor of Medicine at University of Cincinnati College of Medicine, Medical Director, Onconephrology Service of UC Health Cancer Survivorship Program.
Sunday, August 23, 2026
3:00 PM ET
Free for verified healthcare professionals
A change in kidney function can create a consequential decision: continue treatment, pause it, intervene – or safely try again later.
Dr. Gudsoorkar will present a practical framework for recognizing and diagnosing therapy-related kidney injury, determining when cancer treatment should be withheld, and approaching treatment and safe rechallenge.
For colleagues in oncology and nephrology: Which treatment-related kidney complication creates the greatest uncertainty in your practice?
Disclaimer: Views expressed are my own and do not represent the US Department of Veteran Affairs or the United States Government.”
Other articles about Օnco-Nephrology on OncoDaily.
